IP Library Granted Patent US 8,696,545
Granted Patent B2
US 8,696,545 · App. 13/755,644 · Granted Apr 15, 2014

System and method for minimally invasive disease therapy

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,696,545
App. No.
13/755,644
Granted
Apr 15, 2014
Kind
B2
Abstract

A system for treating a lesion site of a patient is disclosed. The system includes a cannula having a lumen, a conduit in communication with said lumen, an introducer stylet removably disposed within said cannula, a resecting device selectively insertable within said cannula, and an adjuvant treatment device selectively insertable within said cannula.

Claims (13)

1. A system for treating a lesion, comprising:

an introducer cannula defining a lumen therein;

a stylet configured to be removably inserted into the cannula lumen;

a resecting device configured to remove the lesion after being removably inserted into the cannula lumen, thereby creating a cavity within tissue adjacent the lesion;

an adjuvant treatment device configured to be removably inserted into the respective cannula lumen and tissue cavity, the adjuvant treatment device configured to deliver an adjuvant treatment to the tissue adjacent the lesion; and

a vacuum source fluidly connected to the cannula lumen so as to deliver vacuum to the tissue cavity while the adjuvant treatment device is disposed within the cannula lumen and tissue cavity, such that the tissue defining the tissue cavity collapses onto a distal end portion of the adjuvant treatment device disposed within the tissue cavity.

2. The system of claim 1 , wherein the adjuvant treatment device is a brachytherapy device.

3. The system of claim 2 , wherein the brachytherapy device comprises

a tubular body defining a first tubular body lumen,

an expandable body attached to the tubular body, and

a radiation source configured to be removably inserted through the first tubular body lumen and into the expandable body.

4. The system of claim 3 , wherein the tubular body further defines a second tubular body lumen and an inflation port inside of the expandable body, wherein the inflation port is fluidly connected to the second tubular body lumen.

5. The system of claim 1 , wherein, when the adjuvant treatment device is inserted into the cannula lumen, the introducer cannula and the adjuvant treatment device together define an annular lumen fluidly connecting the vacuum source to the tissue cavity.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075566/0039 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE R/F 030147 0812 Recorded Jul 17, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 036127/0315 →
SECURITY AGREEMENT Recorded Apr 4, 2013
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED; DIRECT RADIOGRAPHY CORP.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 030147/0812 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 26, 2013
From: NICOSON, ZACHARY R.; MARK, JOSEPH L.
To: SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 030083/0751 →